Ahpra and the National Boards work in partnership to ensure the National Scheme operates efficiently, effectively and economically. The financial statements section of the annual report describes the scheme’s position and performance in more detail. 

In accordance with the Health Practitioner Regulation National Law Act 2009 (the National Law), Ahpra’s financial statements are prepared under Australian Accounting Standards and audited by the auditor-general of a participating jurisdiction. Since Ahpra is headquartered in Melbourne, the Victorian Auditor-General’s Office (VAGO) was appointed to undertake the audit.

Financial overview

Key financial information for the past five years is summarised in Table 39. Income and expenses have increased in each of these years in line with growth of and continuing investment in the scheme. 

The comprehensive result for each period fluctuates to meet the demand from increased regulatory activity and planned investment in health workforce and public safety objectives. Accounting for other economic flows, the comprehensive result of $3.6 million deficit for 2024/25 is a decrease of $11.0 million from a $7.4 million surplus in 2023/24.

Financial performance

An operating deficit of $3.6 million was favourable to the planned budget for 2024/25, as costs associated with the growth in regulatory activity and technology investment were met from within the budget. 

The income of $358.1 million is an increase of $40.7 million from 2023/24. This is the result of health workforce growth and improved returns on financial assets. 

The fees for each National Board for 2024/25 were set to recover the full costs of regulation for each profession. In some cases, these fees were indexed up to 5% in line with higher inflation. For professions with very strong equity balances, fees were not increased. 

Total expenses from transactions of $362.4 million is an increase of $49.6 million from 2023/24. Increased expenditure was required to meet wage inflation, organisation growth, cybersecurity investments, and in accounting for technology development costs.

Financial position

Assets 

Total assets of $359.8 million were held at 30 June. This is a net increase of $32.1 million in line with scheme growth and investment performance. Prepayment assets decreased by $7.1 million in 2024/25. This reduction includes expensing configuration and customisation costs associated with cloud-based technology solutions in line with the applicable accounting policy and the terms of the underlying contracts. 

Intangible technology assets declined to $22.0 million from $25.4 million in 2023/24 as systems came into use and were expensed. 

Property lease assets increased to $40.6 million with the amortisation of existing leases offset by the recognition of new property lease agreements. 

Liabilities 

Liabilities increased to $260.8 million, up from $225.2 million in the previous year. This change reflects $9.2 million in higher registration and examination fees held in advance, $7.1 million in prepaid service income to fund projects arising from the Independent review of Australia’s regulatory settings relating to overseas health practitioners (the Kruk review), $4.4 million growth in employee benefit provisions, and recognition and remeasurement of property lease agreements. 

Equity 

Scheme equity decreased to $99.0 million in line with the $3.6 million operating deficit for the year. Equity is vital to the financial sustainability of the scheme. Its purposes include: 

• mitigating against unexpected loss not covered by our comprehensive insurance 
• funding capital and strategic projects that support the effective and efficient operation of the scheme 
• offsetting the impact to the financial position due to variance in the operating result. 

At 30 June 2025, the scheme remains in a strong financial position, having invested in a significant technology program, external reviews, and other strategic initiatives to advance public safety outcomes.

The year ahead

In 2025/26, an operating deficit is planned, which will draw upon equity reserves. This reflects strategic investment in regulatory reform, our technology program, elimination of racism in healthcare, and actions arising from the Independent review of complexity in the National Registration and Accreditation Scheme (the Dawson review). Regulatory activities are projected to be self-funding, with break-even results anticipated in line with the five-year financial plan.

Financial statements

Statement of comprehensive income for the year ended 30 June 2025

This statement should be read in conjunction with the accompanying notes that are in the full version of the annual report.

Statement of financial position as at 30 June 2025

This statement should be read in conjunction with the accompanying notes that are in the full version of the annual report.

Statement of changes in equity for the year ended 30 June 2025

This statement should be read in conjunction with the accompanying notes that are in the full version of the annual report.

Statement of cash flows for the year ended 30 June 2025

This statement should be read in conjunction with the accompanying notes that are in the full version of the annual report.
All amounts are inclusive of GST.